GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tien Liang BioTech Co Ltd (ROCO:4127) » Definitions » Shiller PE Ratio

Tien Liang BioTech Co (ROCO:4127) Shiller PE Ratio : (As of Sep. 21, 2024)


View and export this data going back to 2005. Start your Free Trial

What is Tien Liang BioTech Co Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Tien Liang BioTech Co Shiller PE Ratio Historical Data

The historical data trend for Tien Liang BioTech Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tien Liang BioTech Co Shiller PE Ratio Chart

Tien Liang BioTech Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Tien Liang BioTech Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Tien Liang BioTech Co's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Tien Liang BioTech Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tien Liang BioTech Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tien Liang BioTech Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Tien Liang BioTech Co's Shiller PE Ratio falls into.



Tien Liang BioTech Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Tien Liang BioTech Co's E10 for the quarter that ended in Jun. 2024 is calculated as:

For example, Tien Liang BioTech Co's adjusted earnings per share data for the three months ended in Jun. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=-0.08/132.5538*132.5538
=-0.080

Current CPI (Jun. 2024) = 132.5538.

Tien Liang BioTech Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201409 0.340 100.428 0.449
201412 0.330 99.070 0.442
201503 0.650 99.621 0.865
201506 0.350 100.684 0.461
201509 0.130 100.392 0.172
201512 -0.050 99.792 -0.066
201603 0.100 100.470 0.132
201606 -0.200 101.688 -0.261
201609 -0.430 101.861 -0.560
201612 -0.640 101.863 -0.833
201703 -0.380 102.862 -0.490
201706 -5.480 103.349 -7.029
201709 1.470 104.136 1.871
201712 -0.060 104.011 -0.076
201803 -0.210 105.290 -0.264
201806 -0.390 106.317 -0.486
201809 -0.790 106.507 -0.983
201812 -0.680 105.998 -0.850
201903 -0.400 107.251 -0.494
201906 -0.350 108.070 -0.429
201909 -0.550 108.329 -0.673
201912 0.276 108.420 0.337
202003 -0.050 108.902 -0.061
202006 -0.390 108.767 -0.475
202009 -0.400 109.815 -0.483
202012 -0.290 109.897 -0.350
202103 -0.260 111.754 -0.308
202106 0.260 114.631 0.301
202109 0.450 115.734 0.515
202112 0.570 117.630 0.642
202203 0.540 121.301 0.590
202206 0.220 125.017 0.233
202209 0.200 125.227 0.212
202212 0.340 125.222 0.360
202303 0.140 127.348 0.146
202306 0.120 128.729 0.124
202309 -0.030 129.860 -0.031
202312 0.160 129.419 0.164
202403 0.170 131.776 0.171
202406 -0.080 132.554 -0.080

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Tien Liang BioTech Co  (ROCO:4127) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Tien Liang BioTech Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Tien Liang BioTech Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Tien Liang BioTech Co Business Description

Traded in Other Exchanges
N/A
Address
Datong Road, 9F, No. 147, Sec. 1, Xizhi District, New Taipei City, TWN
Tien Liang BioTech Co Ltd develops and supplies chemicals, pharmaceutical and Chinese herbs. It offers products for the treatment of intestinal track disease, osteoporosis, eye drops, cholesterin content, angiosclerosis and hepatic diseases.

Tien Liang BioTech Co Headlines

No Headlines